Abstract
Clinical manifestations of leptospirosis range from mild, common cold-like illness, to a life-threatening condition. The host immune response has been hypothesized to play a major role in leptospirosis outcome. Increased levels of inflammatory mediators, such as cytokines, may promote tissue damage that lead to increased disease severity. The question is whether cytokines levels may predict the outcome of leptospirosis and guide patient management. This study aimed to assess the association between Th1-, Th2-, and Th17-related cytokines with the clinical outcome of patients with leptospirosis. Different cytokine levels were measured in fifty-two plasma samples of hospitalized patients diagnosed with leptospirosis in Malaysia (January 2016–December 2017). Patients were divided into two separate categories: survived (n = 40) and fatal outcome (n = 12). Nineteen plasma samples from healthy individuals were obtained as controls. Cytokine quantification was performed using Simple Plex™ assays from ProteinSimple (San Jose, CA, USA). Measurements were done in triplicate and statistical analysis was performed using GraphPad software and SPSS v20. IL-6 (p = 0.033), IL-17A (p = 0.022), and IL-22 (p = 0.046) were significantly elevated in fatal cases. IL-17A concentration (OR 1.115; 95% CI 1.010–1.231) appeared to be an independent predictor of fatality of leptospirosis. Significantly higher levels of TNF-α (p ≤ 0.0001), IL-6 (p ≤ 0.0001), IL-10 (p ≤ 0.0001), IL-12 (p ≤ 0.0001), IL17A (p ≤ 0.0001), and IL-18 (p ≤ 0.0001) were observed among leptospirosis patients in comparison with healthy controls. Our study shows that certain cytokine levels may serve as possible prognostic biomarkers in leptospirosis patients.
Similar content being viewed by others
Data availability
All the data supporting the conclusions of this article are included within the article.
References
Cagliero J, Villanueva SYAM, Matsui M (2018) Leptospirosis pathophysiology: into the storm of cytokines. Front Cell Infect Microbiol 8:1–8. https://doi.org/10.3389/fcimb.2018.00204
Chin V, Lee T, Lim W et al (2018) Leptospirosis in human: biomarkers in host immune responses. Microbiol Res 207:108–115. https://doi.org/10.1016/j.micres.2017.11.015
Wang H, Wu Y, Ojcius DM et al (2012) Leptospiral hemolysins induce proinflammatory cytokines through toll-like receptor 2-and 4-mediated JNK and NF-κB signaling pathways. PLoS One 7. https://doi.org/10.1371/journal.pone.0042266
Lee SH, Kim S, Park SC, Kim MJ (2002) Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells. Infect Immun 70:315–322. https://doi.org/10.1128/IAI.70.1.315
Hoke DE, Egan S, Cullen PA, Adler B (2008) LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect Immun 76:2063–2069. https://doi.org/10.1128/IAI.01643-07
Nahori M-A, Fournié-Amazouz E, Que-Gewirth NS et al (2005) Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J Immunol 175:6022–6031. https://doi.org/10.4049/jimmunol.175.9.6022
Papa A, Kotrotsiou T (2015) Cytokines in human leptospirosis. Trans R Soc Trop Med Hyg 109:749–754. https://doi.org/10.1093/trstmh/trv095
Mikulski M, Boisier P, Lacassin F et al (2015) Severity markers in severe leptospirosis: a cohort study. Eur J Clin Microbiol Infect Dis 34:687–695. https://doi.org/10.1007/s10096-014-2275-8
Reis EAG, Hagan JE, Ribeiro GS et al (2013) Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. PLoS Negl Trop Dis 7:e2457. https://doi.org/10.1371/journal.pntd.0002457
Kyriakidis I, Samara P, Papa A (2011) Serum TNF- alpha , sTNFR1, IL-6, IL-8 and IL-10 levels in Weil’s syndrome. Cytokine 54:117–120. https://doi.org/10.1016/j.cyto.2011.01.014
Tajiki H, Salomao R (1996) Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis 23:1177–1178
Estavoyer JM, Racadot E, Couetdic G et al (1991) Tumor necrosis factor in patients with leptospirosis. Rev Infect Dis 13:1245–1246
Chirathaworn C, Supputtamongkol Y, Lertmaharit S, Poovorawan Y (2016) Cytokine levels as biomarkers for leptospirosis patients. Cytokine 85:80–82. https://doi.org/10.1016/j.cyto.2016.06.007
Leptospirosis Burden Epidemiology Reference Group (LERG) (2011) Report of the Second Meeting of the Leptospirosis Burden Epidemiology Reference Group
Aldo P, Marusov G, Svancara D et al (2016) Simple plexTM: a novel multi-analyte, automated microfluidic immunoassay platform for the detection of human and mouse cytokines and chemokines. Am J Reprod Immunol 75:678–693. https://doi.org/10.1111/aji.12512
Bandara K, Gunasekara C, Weerasekera M et al (2018) Do the Th17 cells play a role in the pathogenesis of leptospirosis? Can J Infect Dis Med Microbiol 2018. https://doi.org/10.1155/2018/9704532
Rizvi M, Azam M, Ajmal MR et al (2011) Prevalence of leptospira in acute hepatitis syndrome and assessment of IL-8 and TNF-alpha level in leptospiral hepatitis. Ann Trop Med Parasitol 105:499–506. https://doi.org/10.1179/1364859411Y.0000000041
Fernando N, De Silva R, Handunnetti SM et al (2018) Effect of antimicrobial agents on inflammatory cytokines in acute leptospirosis. Antimicrob Agents Chemother 62. https://doi.org/10.1128/AAC.02312-17
Jumat MI, William T, John DV (2018) Cytokine profile of patients with leptospirosis in Sabah, Malaysia. Med J Malaysia 73:106–109
Acknowledgments
A special thank-you to the Director General of Health Malaysia, Ministry of Health Malaysia, for his permission to publish this article and the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, for the facilities and technical support provided.
Funding
This study was funded by the Ministry of Higher Education Malaysia through the Long-Term Research Grant Scheme (LRGS) (UPM/700-2/1/LRGS/5526402).
Author information
Authors and Affiliations
Contributions
SAN, MA, and ZS were involved in the conception and design of the study. WSY performed the study, analyzed data, and drafted the manuscript. AvB substantially revised the analyses and manuscript. MYY, AMS, and NMT provided clinical data and sample. LT, IK, and FA contributed intellectual content to the study. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval and consent to participate
Samples were collected from study participants after they have given their written informed consent. Ethical approval for the study was obtained from the Medical Research and Ethics Committee, Ministry of Health Malaysia (NMRR (National Medical Research Register)-15-2148-27536 and NMRR-15-756-25320).
Informed consent
Written informed consent was obtained from the study participants for publication of their individual details in this manuscript.
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wan Yusoff, W.S.Y., Abdullah, M., Sekawi, Z. et al. Raised levels of Il-6, Il-17a, and Il-22 in fatal leptospirosis. Eur J Clin Microbiol Infect Dis 38, 2349–2353 (2019). https://doi.org/10.1007/s10096-019-03699-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-019-03699-5